Nykredit A S purchased a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 131,738 shares of the real estate investment trust’s stock, valued at approximately $11,698,000.
Several other hedge funds have also made changes to their positions in the company. Deutsche Bank AG boosted its position in Ventas by 0.7% during the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after acquiring an additional 27,688 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Ventas by 2.5% in the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after purchasing an additional 70,459 shares during the period. Norges Bank acquired a new position in shares of Ventas in the 4th quarter valued at about $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Ventas by 7.4% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after purchasing an additional 92,236 shares in the last quarter. Finally, Sei Investments Co. lifted its position in shares of Ventas by 3.3% in the first quarter. Sei Investments Co. now owns 660,428 shares of the real estate investment trust’s stock worth $54,010,000 after purchasing an additional 21,378 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Wall Street Analyst Weigh In
VTR has been the topic of a number of research analyst reports. Barclays boosted their price objective on shares of Ventas from $99.00 to $102.00 and gave the company an “equal weight” rating in a research report on Monday. Scotiabank lifted their target price on shares of Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research note on Wednesday. Raymond James Financial initiated coverage on shares of Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target on the stock. Mizuho increased their price objective on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $99.00.
Ventas Stock Performance
VTR stock opened at $90.27 on Friday. The firm has a 50 day moving average of $92.94 and a two-hundred day moving average of $87.82. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a market capitalization of $46.30 billion, a price-to-earnings ratio of 167.17, a P/E/G ratio of 3.59 and a beta of 0.70. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the firm earned $0.87 EPS. Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. As a group, equities analysts anticipate that Ventas, Inc. will post 3.89 EPS for the current fiscal year.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
